CCL16



CCL16

Q1QQ1P2PP2K3KK3V4VV4P5PP5E6EE6W7WW7V8VV8N9NN9T10TT10P11PP11S12SS12T13TT13C14CC14C15CC15L16LL16K17KK17Y18YY18Y19YY19E20EE20K21KK21V22VV22L23LL23P24PP24R25RR25R26RR26L27LL27V28VV28V29VV29G30GG30Y31YY31R32RR32K33KK33A34AA34L35LL35N36NN36C37CC37H38HH38L39LL39P40PP40A41AA41I42II42I43II43F44FF44V45VV45T46TT46K47KK47... and 50 more residue(s)...... and 50 more residue(s)

SMILES None
InChIKey None
Sequence QPKVPEWVNTPSTCCLKYYEKVLPRRLVVGYRKALNCHLPAIIFVTKRNREVCTNPNDDWVQEYIKDPNLPLLPTRNLSTVKIITAKNGQPQLLNSQ

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL16

Q1QQ1P2PP2K3KK3V4VV4P5PP5E6EE6W7WW7V8VV8N9NN9T10TT10P11PP11S12SS12T13TT13C14CC14C15CC15L16LL16K17KK17Y18YY18Y19YY19E20EE20K21KK21V22VV22L23LL23P24PP24R25RR25R26RR26L27LL27V28VV28V29VV29G30GG30Y31YY31R32RR32K33KK33A34AA34L35LL35N36NN36C37CC37H38HH38L39LL39P40PP40A41AA41I42II42I43II43F44FF44V45VV45T46TT46K47KK47... and 50 more residue(s)...... and 50 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.